Cystic fibrosis(CF) severity and polymorphisms(pol) in ACE, GCLC and GST(M1, T1 and P1) genes

F. A. D. L. Marson, J. D. Ribeiro, C. S. Bertuzzo, A. F. Ribeiro (Campinas, Brazil)

Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Session: Cystic fibrosis: clinical and laboratory studies
Session type: Thematic Poster Session
Number: 2659

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. A. D. L. Marson, J. D. Ribeiro, C. S. Bertuzzo, A. F. Ribeiro (Campinas, Brazil). Cystic fibrosis(CF) severity and polymorphisms(pol) in ACE, GCLC and GST(M1, T1 and P1) genes. Eur Respir J 2010; 36: Suppl. 54, 2659

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF)
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Effects of glutation-S-transferase M1 (GSTM1) and T1 (GSTT1) and matrix metalloproteinase 9 (MMP9) on the decline of lung function in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004

Dependence of stage of severity of chronic obstructive pulmonary disease on metalloproteinase 1, 12, surfactant protein C, microsomal epoxid hydrolase gene polymorphisms
Source: Eur Respir J 2006; 28: Suppl. 50, 523s
Year: 2006

The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS)
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Analysis the variation of antioxidant-related genes: glutathione transferases (M1, T1, P1), catalase, glutathione peroxidase 1 and NAD(P)H: quinone oxidoreductase-1 and their relationship to chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 635s
Year: 2006

Association of single nucleotide polymorphisms in 4 genes (VDR, COL1A1, CALCR and BGLAP) with susceptibility to steroid osteoporosis in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Correlation between change in lung density and lung function parameters in treated alpha-1 protease inhibitor (A1-PI) deficiency
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016



The role of genetic polymorphisms of glutation-S-transferase μ1 (GSTM1) and gelatinase B (MMP9) in the risk of COPD development
Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD
Year: 2003


Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles
Source: Eur Respir J 2004; 24 : 798-804
Year: 2004



ADRB2R gene polymorphism (pol.) associated with the severity of cystic fibrosis(CF) and the effectiveness of the use of inhaled bronchodilator
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Metabolic gene polymorphisms (CYP1A1, EPHX1, GSTM1 and GSTP1) associations with the severity of cystic fibfosis airway disease
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

Determination of a single nucleotide polymorphism (SNP) of the TNFalpha-R1 region (TNFRSF1A) in patients with lung sarcoidosis: Preliminary results
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Increased proportion of slow decliners in patients with alpha-1 protease inhibitor (A1-PI) deficiency following treatment with A1-PI
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016


Polymorphisms of the aph-1 homolog A, gamma-secretase subunit (APH1A) gene in Japanese patients with aspirin-exacerbated respiratory disease (AERD).
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017

Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2)
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Plasma uteroglobin-related protein 1 (Ugrp1) levels is associated with Ugrp1 -112G/A polymorphism and the severity of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 592s
Year: 2006

Association of FCN1 and FCN2 gene polymorphisms with earlier onset of chronic pseudomonas aeruginosa (Pa) colonisation in cystic fibrosis (CF) patients
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011



Novel assessment of alpha galactosidase A enzyme (GLA) activity in induced sputum (IS) and blood in patients with Anderson Fabry disease (AFD)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014